No Data
No Data
Guanhao Biotech (300238.SZ) appoints Yi Ruofeng as the financial head.
Guanhao Biotech (300238.SZ) announced that the board of directors of the company recently received the resignation report submitted by Zhang Weikun...
Guanhao Biotech (300238.SZ): As of July 19th, the total number of shareholders in the company is 31,960.
Guanhao Biotech (300238.SZ) stated on the investor interactive platform on July 22nd that as of July 19, 2024, the total number of shareholders in the company was 31,960.
As of July 10th, 2024, the total number of shareholders for guanhao biotech (300238.SZ) was 32,054.
Guanhao Biotech (300238.SZ) stated on the investor interaction platform that as of July 10, 2024, the total number of shareholders of the company is 32,054.
Guanhao biotech (300238.SZ): the Phase III clinical trial of Benvimode cream for atopic dermatitis is still progressing in an orderly manner.
On July 12th, Gelonhui reported that an investor asked Guanhao Biotech (300238.SZ) on the interactive platform for investors, 'The new indication of pemodermatitis for Bemovate has been in Phase III clinical stage for a long time, please elaborate on the current progress.' The company replied that the Phase III clinical trial of Bemovate cream for special pemodermatitis is still progressing orderly. Please pay attention to the company's announcement for follow-up progress.
AH trends diverge, Hang Seng Index up 0.6%, CNOOC up 4%, national bond futures slightly rebound.
Rare earth permanent magnets concept stocks pull back, photovoltaic and lithography themes also weaken. Hong Kong's real estate, banks, and oil & gas stocks are strong, CNOOC up 4%, Agricultural Bank of China and China Merchants Bank rise more than 2%. After experiencing a sharp drop yesterday, national bond futures rebounded in early trading, with 10-year and 30-year national bond futures contracts rising nearly 0.1% in early trading.
Guanhao Biology (300238.SZ): Does not involve synthetic biology business or related research
Gelonghui May 9 丨 Guanhao Biology (300238.SZ) announced the stock price change announcement. The company paid attention to some media, stock bars and other platforms to discuss synthetic biology and related hot concepts. Currently, the company is not involved in synthetic biology business or related research.
No Data